Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy

Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy

Item
http://www.wikidata.org/entity/Q34091402
Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range.Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technologyObesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy.Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.A risk-adjusted definition of biochemical recurrence after radical prostatectomy.Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study.Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy.Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence.Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur.Stratification model based on early postprostatectomy prostate-specific antigen kinetics may help to reduce the risk of overtreatment in candidates for adjuvant radiotherapy.Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy.Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.The significance of reporting to the thousandths place: Figuring out the laboratory limitations.
P2860

Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy

Item
http://www.wikidata.org/entity/Q34091402
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prognostic implications of an ...... el after radical prostatectomy
@ast
Prognostic implications of an ...... el after radical prostatectomy
@en
Prognostic implications of an ...... el after radical prostatectomy
@nl
type
label
Prognostic implications of an ...... el after radical prostatectomy
@ast
Prognostic implications of an ...... el after radical prostatectomy
@en
Prognostic implications of an ...... el after radical prostatectomy
@nl
prefLabel
Prognostic implications of an ...... el after radical prostatectomy
@ast
Prognostic implications of an ...... el after radical prostatectomy
@en
Prognostic implications of an ...... el after radical prostatectomy
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Prognostic implications of an ...... el after radical prostatectomy
@en
P2093
P2860
P304
P31
P356
10.1016/J.EURURO.2009.03.077
P407
P433
P478
P50
P577
P5875
P698
P932